30 slides from Lassonde Industries, Inc. Class A's earnings presentation, Mar 27, 2026
Slide 1: Investor Presentation
Investor Presentation Fourth quarter and fiscal year ended December 31, 2025 LASSONDE INDUSTRIES INC.
Slide 2: Forward-Looking Statements
2 Forward-Looking Statements and use of financial Forward-Looking Statements measures not in accordance with IFRS This presentation contains “forward-looking information”, and the Corporation’s oral and written public communications that do not constitute historical fact may be deemed to be “forward
Slide 3: Forward-Looking Statements (cont'd)
3 Forward-Looking Statements and use of financial Forward-Looking Statements measures not in accordance with IFRS (cont’d) The Corporation’s ability to achieve its sustainability priorities, targets and goals is further subject to, among other factors, its ability to access and implement all technol
Slide 4: A Solid Performance in 2025
4 A Solid Performance in 2025 A Solid Performance in 2025 Record sales and strong increase in profitability ▪ Despite a challenging and rapidly evolving macroeconomic environment ▪ Each division recorded sales growth Reflects continued focus on executing our strategy ▪ Supported by a deep and divers
Slide 5: U.S. Beverage
5 U.S. Beverage U.S. Beverage Gained market share in the fourth quarter ▪ Higher volume for Lassonde with category down mid-single digits Private label in line with category ▪ Benefits from build-back plan balanced by pricing discipline More important gains in branded business ▪ Shift towards higher
Slide 6: Canadian Beverage
6 Canadian Beverage Canadian Beverage Market share gains driven by national brands ▪ Distribution gains in shelf-stable and chilled products ▪ Strong growth in single-serve formats Disciplined pricing execution Targeted promotions and marketing support ▪ “Oasis of Light” marketing campaign ▪ Benefit
Slide 7: Food Service
7 Food Service Food Service Another strong quarter ▪ U.S.: Volume gains with broadline distributors ▪ Canada: Improved penetration of national accounts “Bag-in-a-box” aseptic packaging line ▪ Deployment is progressing ▪ Active negotiations and bidding processes with large national accounts and other
Slide 8: Specialty Food
8 Specialty Food Specialty Food Continued efforts to integrate our North American network Lower sales at Summer Garden due to lapping a strong quarter in 2024 ▪ Change in third-party sales mix ▪ Timing of certain promotions ▪ System recovery and restoration issues resulting in lost opportunities and
Slide 9: Key Executive Nominations
9 Key Executive Nominations Key Executive Nominations SPECIALTY FOOD DIVISION CORPORATE Jean-Philippe Jamie Bradford Francis Trudeau Minh Quan Dam Leblanc President, Chief Marketing Officer, Executive Chief Information North American North American Vice-President, Officer Specialty Food Specialty Fo
Slide 10: Sales Increase
10 Q4 2025 Sales Increase ($M) Sales Increase Key Highlights $768.1 $738.1 ✓ Selling price adjustments (mainly Canada)▲ $22.6M: +4.1% ▲ $12.7M private labels ▲ $9.9M national brands ✓ Effect of sales volume (mainly U.S.) ▲ $6.8M: ▼ $5.6M private labels ▲ $12.4M national brands ✓ Changes in sales mix
Slide 11: Improved Profitability
11 Q4 2025 Improved Profitability Improved Profitability Gross Profit ($M) Operating Profit ($M) Adjusted EBITDA(1) ($M) $225.0 $71.1 $101.8 $192.9 +16.6% +65.3% $79.6 +27.9% $43.0 29.3% 9.3% 13.3% 26.1% 5.8% 10.8% 2024 2025 2024 2025 2024 2025 Key Highlights SG&A expenses increased slightly Signifi
Slide 12: Improved Profitability (cont'd)
12 Q4 2025 Improved Profitability (cont’d) Improved Profitability Profit Attributable to the Adjusted Profit Attributable to the Shareholders ($M) & EPS Shareholders(1) ($M) & Adjusted EPS(1) $54.0 $51.3 +46.6% +99.2% $35.0 $7.92 $7.52 $27.1 $5.13 $3.97 2024 2025 2024 2025 (1) Financial measure not
Slide 13: Fiscal 2025 - Financial Highlights
13 Fiscal 2025 Financial Highlights Fiscal 2025 - Financial Highlights Operating Profit ($M) Adjusted EBITDA(1) ($M) $344.1 Sales ($M) $226.1 $275.8 +24.7% $174.7 +29.4% $2,934.0 $2,600.9 +12.8% 7.7% 11.7% 10.6% 6.7% 2024 2025 2024 2025 Profit Attributable to the Adjusted Profit Attributable to the
Slide 14: Days Operating Working Capital
14 Q4 2025 Days Operating Working Capital (1) Days Operating Working Capital 100 92 90 85 84 79 78 80 70 Within 60 59 historical 53 56 59 range Days 48 50 43 42 38 40 40 36 30 23 23 22 19 17 20 10 0 Q4-17 Q4-18 Q4-19 Q4-20 Q4-21 Q4-22 Q4-23 Q4-24 Q1-25 Q2-25 Q3-25 Q4-25 DSO (1) DIO (1) DPO (1) Days
Slide 15: Cash Flows
15 Q4 2025 Cash Flows ($M) Cash Flows Operating Activities Key Highlights $233.9 $176.2 ✓ Higher operating cash flows in Q4-2025 $121.5 ▪ Higher profitability $75.7 ▪ Stronger working capital performance ▪ Lower inventory 2024 Q4 Year ✓ CAPEX of $44.8M in Q4-2025; $187.2M for the full year Acquisiti
Slide 16: Financial Position
16 Q4 2025 Financial Position ($M) Financial Position 750 $618.1 $595.5 $587.1 $553.9 600 $549.5 $504.0 $489.3 $444.6 $449.3 $417.3 450 1.99x 2.03x 300 1.63x 1.71x $226.1 1.42x $182.9 $187.3 $197.0 $174.7 150 0 Dec. 31, March 29, June 28, Sept. 27, Dec. 31, Dec. 31, March 29, June 28, Sept. 27, Dec.
Slide 17: 2026 Outlook
17 2026 Outlook 2026 Outlook Entering 2026 from a position of strength Priorities are executing our strategy and maintaining our focus on capturing profitable growth ▪ Mindful of a challenging macro environment Continue to leverage our diversified portfolio Anticipate achieving our stated goal of $3
Slide 18: Focus on Executing Strategic Priorities
18 Focus on Executing Strategic Priorities Focus on Executing Strategic Priorities U.S. Beverage ▪ Continue private label volume build-back plan ▪ Deliver capacity ramp-ups for single-serve and juice box lines ▪ Maintain pricing discipline ▪ Complete the construction of the New Jersey facility Canad
Slide 19: Risk Factors
19 Risk Factors(1) Risk Factors Costs ▪ Easing in orange concentrate vs. 2025 spot levels ▪ Realized benefits will depend on the timing of our hedges and other risk mitigation actions ▪ Cautious market sentiment for apple juice concentrate ▪ Regional supply constraints are preventing significant pri
Slide 20: Conclusion
20 Conclusion Conclusion We expect to deliver another solid performance in 2026 Focused on executing our strategy and capturing growth opportunities Building our capacity to act through talent, capabilities and winning culture ▪ New leadership in finance and IT ▪ New organization structure ▪ Support
Slide 21: Financial Measures Not in Accordance with IFRS
Financial Measures Not in Accordance with IFRS
Slide 22: Financial Measures Not in Accordance with IFRS
22 Financial Measures Not in Accordance with IFRS Financial Measures Not in Accordance with IFRS Items impacting the comparability between periods The table on the right contains a list, description and quantification of items impacting the comparability of the financial performance between the peri
Slide 23: Financial Measures Not in Accordance with IFRS (cont'd)
23 Financial Measures Not in Accordance with IFRS (cont’d) Financial Measures Not in Accordance with IFRS Adjusted Profit Attributable to the Corporation’s Shareholders and Adjusted EPS Adjusted profit attributable to the Corporation’s shareholders is a financial measure and adjusted EPS (composed n
Slide 24: Financial Measures Not in Accordance with IFRS (cont'd)
24 Financial Measures Not in Accordance with IFRS (cont’d) Operating Working Capital and Days Operating Working Capital is a financial measure and days operating working capital is a financial ratio that are used by the Corporation to monitor the Financial Measures Not in Accordance with IFRS effici
Slide 25: Key Information
Key Information
Slide 26: Financial Highlights
26 Financial Highlights Financial Highlights (1) This measure does not constitute a standardized financial measure in accordance with the financial reporting framework used to prepare the Corporation's financial statements. Comparing it to a similar financial measure presented by other issuers may n
Slide 27: Sales Evolution
27 Sales Evolution Sales Evolution
Slide 28: Evolution – Frozen Concentrate Orange Juice
28 Evolution – Frozen Concentrate Orange Juice Frozen Concentrate Orange Juice Source: Trading Economics
Slide 29: Evolution – Apple Juice Concentrate
29 Evolution – Apple Juice Concentrate Apple Juice Concentrate Source: US Department of Agriculture
Slide 30: lassonde.com
B Lassonde lassonde.com